Platelet function in infection and sepsis - A bicentric cohort study

Platelet function in infection and sepsis - A bicentric cohort study - /

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028159

Enrollment

300

Registered

2022-04-05

Start date

2022-06-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 A41

Interventions

Group 1: Sepsis/Septic Shock. Blood withdrawal is scheduled at two predefined time-points (Hospital/ICU admission, day 5-7 at ICU) Group 2: Infection - non sepsis. Blood withdrawal is scheduled at t

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Assumed or confirmed infection -Age of 18 a or older -Written consent of patient or legal guardian

Exclusion criteria

Exclusion criteria: - pregnancy or lactation period - aplasia after chemotherapy oder HSCT

Design outcomes

Primary

Measure	Time frame
CD62P-expression upon GPVI stimulation at hospital admission	—

Secondary

Measure	Time frame
30 day and 6 month survival (after ICU discharge)	—

Countries

Germany

Contacts

Public ContactHarald Schulze

Institut für Experimentelle Biomedizin Lehrstuhl I Universitätsklinikum Würzburg

harald.schulze@uni-wuerzburg.de0931 201 48329

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026